These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 24433930)
1. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes. Mahrooz A; Alizadeh A; Gohari G J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930 [TBL] [Abstract][Full Text] [Related]
2. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
3. R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke. Mahrooz A; Gohari G; Hashemi MB; Zargari M; Musavi H; Abedini M; Alizadeh A Mol Biol Rep; 2012 Dec; 39(12):11177-85. PubMed ID: 23054002 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients. Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140 [TBL] [Abstract][Full Text] [Related]
5. Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population. Demirdöğen BC; Demirkaya S; Türkanoğlu A; Bek S; Arinç E; Adali O Cell Biochem Funct; 2009 Dec; 27(8):558-67. PubMed ID: 19902425 [TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130 [TBL] [Abstract][Full Text] [Related]
7. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals. Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252 [TBL] [Abstract][Full Text] [Related]
8. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans. Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase phenotype distribution in a healthy Iranian population. Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311 [TBL] [Abstract][Full Text] [Related]
10. Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke. Kim NS; Kang BK; Cha MH; Oh SM; Ko MM; Bang OS Clin Biochem; 2009 Jun; 42(9):857-63. PubMed ID: 19233151 [TBL] [Abstract][Full Text] [Related]
11. The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes. Zargari M; Sharafeddin F; Mahrooz A; Alizadeh A; Masoumi P Exp Biol Med (Maywood); 2016 Aug; 241(14):1489-96. PubMed ID: 27022137 [TBL] [Abstract][Full Text] [Related]
12. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate. Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910 [TBL] [Abstract][Full Text] [Related]
13. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811 [TBL] [Abstract][Full Text] [Related]
14. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192). Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822 [TBL] [Abstract][Full Text] [Related]
15. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein. Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834 [TBL] [Abstract][Full Text] [Related]
17. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901 [TBL] [Abstract][Full Text] [Related]
18. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651 [TBL] [Abstract][Full Text] [Related]
19. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
20. Paraoxonase activity in healthy, diabetic, and hemodialysis patients. Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]